Evaluation of membrane type 1 metalloproteinase (MT1-MMP/MMP14) expression as a prognostic biomarker in patients with solid tumours screened for a Phase I/II trial (2022)
Attributed to:
MICA: The Newcastle Proximity Laboratory
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0959-8049(22)01114-5
Publication URI: http://dx.doi.org/10.1016/s0959-8049(22)01114-5
Type: Journal Article/Review
Parent Publication: European Journal of Cancer